SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 189.55+3.5%Dec 12 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mudcat who wrote (26490)11/14/1998 11:23:00 PM
From: Cheryl Galt  Read Replies (2) of 32384
 
Mudcat, the revenues for 3Q98 were much the same as for 2Q98. And the loss from operations was identical, 16,275,000. (How's that for an arithmetic coincidence?)
It sounds to me like progress was delayed a quarter, pretty normal for pre-profit biotechs.

The big difference in this 3Q quarter report is that we're sure the company has money for the next year of operations, and we really are on the brink of commercialization.

Because of that 30mm one-time charge, we may get on the lists of negative earnings surprises Monday morning, and maybe get a chance to pick up a quick bargain position. And I do NOT mean that sarcastically.

News about the FDA meeting likely won't come until Monday after close, or Tuesday.
Monday could be bargain day.

Cheryl

BTW, the 3Q eps of -.40 would have been about -.50 if computed with the 32.8mm shares outstanding in 3Q 1997. Thank dilution for the better sounding eps.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext